ICON will be participating in ACOP 2025 in Aurora, Colorado, where we will introduce Yi Zhang, our new Scientific Director of PK in the Pharmacometrics Department. Yi brings extensive expertise in PK/PD modeling, disea...
Clinical, consulting and commercial services
ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.
-
Adaptive trials
ICON offers the knowledge, software, systems and global footprint to make global adaptive trials a reality.
-
Cardiac Safety Solutions
Ensuring the highest levels of safety and accuracy in your trials.
-
Clinical & Scientific Operations
ICON provides a range of integrated services that cover the planning, management, execution and analysis of Phase II – IIIb trials.
-
Consulting
ICON Consulting Services provides strategic analysis to support improved decision-making in drug and device development.
-
Commercial Positioning
ICON provides expertise to accelerate market access and drive product adoption.
-
Decentralised clinical trials
ICON experts can help to implement patient-centric, alternative trial models - from the integration of digital health technologies to in-home clinical visits and agile monitoring solutions.
-
Early Clinical
ICON specialises in the strategy and delivery of early phase clinical development.
-
Laboratories
ICON provides laboratory services through our global Central Laboratories, Bioanalytical Laboratory and Specialty Laboratories.
-
Language Services
ICON is the industry's largest life sciences language services provider.
-
Medical Imaging
ICON provides medical imaging based product development services that expedite drug development.
-
Real World Intelligence
ICON optimises real world data use to drive effective outcomes and achieve regulatory authorisation
-
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
-
Strategic Solutions
ICON is redefining FSP to provide sponsors with flexibility to meet the demands of modern drug development.
